William R. Jellison

Sits on 4 boards. Last updated September 28, 2026

Time on boards

Boards served
4
Current seats
4
Board service
8 years
Director since
2023

8 years of board service in total across 4 boards, counting each seat separately. Longest: Avient Corporation, 3 years.

3 years · Since 2023
2 years · Since 2024
Medtronic plc. Director
1 year · Since 2025
6 months · Since 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 30, 2026 Avient Corporation Grant or award +958 — —
Jun 30, 2026 Avient Corporation Grant or award +1,049 — —
Apr 27, 2026 Medtronic plc. Grant or award +1,444 — —
Mar 31, 2026 Avient Corporation Grant or award +1,072 — —
Dec 31, 2025 Avient Corporation Grant or award +1,239 — —
Sep 30, 2025 Avient Corporation Grant or award +1,192 — —
Aug 25, 2025 Medtronic plc. Open-market purchase +2,500 $92.37 $230,925
Aug 22, 2025 Medtronic plc. Open-market purchase +2,500 $92.73 $231,825
Jun 30, 2025 Avient Corporation Grant or award +1,187 — —
Jun 20, 2025 Anika Therapeutics Inc. Grant or award +14,164 — —
Mar 31, 2025 Avient Corporation Grant or award +1,055 — —
Dec 31, 2024 Avient Corporation Grant or award +955 — —
Sep 30, 2024 Avient Corporation Grant or award +775 — —
Jul 9, 2024 Anika Therapeutics Inc. Grant or award +5,771 — —
Jun 28, 2024 Avient Corporation Grant or award +806 — —

Questions about William R. Jellison

What boards is William R. Jellison on?

William R. Jellison sits on the boards of Anika Therapeutics Inc., Avient Corporation, Medtronic plc. and Telix Pharmaceuticals Limited.

How long has William R. Jellison served on boards?

Our records show at least 8 years of board service across 4 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.